What is the current Price Target for the KalVista Pharmaceuticals, Inc. stock?

The average KalVista Pharmaceuticals, Inc. target price is $26.33. This is 137.45% higher than the current stock price. The highest price target is 251.67%, the lowest is 62.31%. 9 Analysts have issued a price target KalVista Pharmaceuticals, Inc. 2026 .

How high will the KalVista Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the KalVista Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the KalVista Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the KalVista Pharmaceuticals, Inc. stock today?

The performance of KalVista Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the KalVista Pharmaceuticals, Inc. stock fall?

The decline in KalVista Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

KalVista Pharmaceuticals, Inc. Forecast, price target & analysts

$11.03

0.54% today

Nasdaq, Apr 03, 06:46 pm CET

ISIN

US4834971032

Symbol

KALV

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

KalVista Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

KalVista Pharmaceuticals, Inc. Classifications & Recommendation:

Buy

100%

KalVista Pharmaceuticals, Inc. Price Target

Target Price	$26.33
Price	$11.09
Potential	137.45% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target KalVista Pharmaceuticals, Inc. 2026 . The average KalVista Pharmaceuticals, Inc. target price is $26.33. This is 137.45% register free of charge higher than the current stock price. The highest price target is $39.00 251.67% register free of charge , the lowest is $18.00 62.31% register free of charge .
	A rating was issued by 10 analysts: 10 Analysts recommend KalVista Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the KalVista Pharmaceuticals, Inc. stock has an average upside potential 2026 of 137.45% register free of charge . Most analysts recommend the KalVista Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Apr '24	2025 Estimates
Earnings Per Share $	-3.44	-3.40
	3.30%	1.16%
P/E		negative

2 Analysts have issued a KalVista Pharmaceuticals, Inc. forecast for earnings per share. The average KalVista Pharmaceuticals, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.44	3.30%
2025	$-3.40 1.16% Unlock
2026	$-2.92 14.12% Unlock

Current	-2.98	21.16%
2025	-3.26 9.40% Unlock
2026	-3.80 16.56% Unlock

KalVista Pharmaceuticals, Inc....

Current KalVista Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Needham	Locked ➜ Locked	Locked	Mar 26 2025
Jones Trading	Locked ➜ Locked	Locked	Mar 26 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Mar 26 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 14 2025
Needham	Locked ➜ Locked	Locked	Mar 13 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Mar 03 2025
JMP Securities	Locked ➜ Locked	Locked	Jan 31 2025

Analyst Rating	Date
Locked Needham: Locked ➜ Locked	Mar 26 2025
Locked Jones Trading: Locked ➜ Locked	Mar 26 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Mar 26 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 14 2025
Locked Needham: Locked ➜ Locked	Mar 13 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Mar 03 2025
Locked JMP Securities: Locked ➜ Locked	Jan 31 2025

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now